Xilin Wang
Education:
B.S. Tufts University (2023)
Advisor:
TBA
Graduate Program:
TBA
Research Interests:
GI Cancer Immunology and Biology
Publications:
Zackery Ely, Zachary Kulstad, Gurcan Gunaydin, Sudarsana Addepalli, Eva Verzani, Marta Casarrubios, Karl Clauser, Xilin Wang, Isabelle Lippincott, Cedric Louvet, Thomas M. Schmitt, Kevin Kapner, Miles Agus, Connor Hennessey, James M. Cleary, Sine Hadrup, Susan Klaeger, Jennifer Su, Alex Jaeger, Brian Wolpin, Srivatsan Raghavan, Eric Smith, Philip Greenberg, Andrew Aguirre, Jennifer Abelin, Steven Carr, Tyler Jacks, William Freed-Pastor. “Cancer-restricted cryptic antigens are targets for T cell recognition”. Science. 2025. May 8; 388(6747).
Conference Posters/Presentations:
Xilin Wang, Alex Blain, Zachary Kulstad, Gurcan Gunaydin, Emanuele Puca, Roberto De Luca, and William Freed-Pastor. An Immunocytokine Targeting EDB-Fibronectin Can Overcome T-cell Exclusion in Preclinical Models of Neoantigen-expressing Pancreatic Cancer. Poster presented at: 21st Annual Broad Institute Scientific Retreat; Boston, MA; December 2025.
Xilin Wang, Zachary Kulstad, Gurcan Gunaydin, Adam Stockman, Ann Cheung, Tyler Jacks, Nathan Felix, James Cleary, and William Freed-Pastor. Exploring the Ability of Extended Half-Life IL-12 to Overcome Immune Evasion in Preclinical Models of Pancreas Cancer. Poster presented at: 20th Annual Broad Institute Scientific Retreat; Boston, MA; December 2024.
Zachary Ely, Zachary Kulstad, Gurcan Gunaydin, Sudarsana Addepalli, Eva Verzani, Jennifer Abelin, Isabella Lippincott, Marta Casarrubios, Karl Clauser, Xilin Wang, Cedric Louvet, Thomas Schmitt, Miles Agus, Kevin Kapner, Connor Hennessey, James Cleary, Sine Hadrup, Susan Klaeger, Jennifer Su, Alex Jaeger, Brian Wolpin, Srivatsan Raghavan, Eric Smith, Philip Greenberg, Andrew Aguirre, Steven Carr, Tyler Jacks, and William Freed-Pastor. Discovery and Therapeutic Potential of Novel Cryptic Peptides in Pancreatic Cancer. Poster presented at: AACR Special Conference In Cancer Research: Advances in Pancreatic Cancer Research; Boston, MA; September 2024.
Rahul Raghav, J Awata, Gayani Perera, Samia Ali, Xilin Wang, Lija Swain, GL. Martin, D Strathdee, R Blanton, N Kapur, and Michael T. Chin. Enzyme Replacement Therapy Rescues Metabolic and Functional Defects in a Mouse Model of Barth Syndrome. Poster presented at: Barth Syndrome Foundation Biennial International Scientific, Medical, and Family Conference; Bonita Springs, FL; July 2024.
Junya Awata, Rahul Raghav, Xilin Wang, and Michael T. Chin. Engineered Isoforms of Tafazzin: Activity, Stability, and Potential Therapeutic Utility. Poster presented at: Barth Syndrome Foundation International Scientific and Medical Symposium; Boston, MA; July 2022.